
𧬠Multi-Edit CAR T-Cells: The Crazy Science That Might Cure Brain Cancer | Aaron Edwards (Part 4/4)
āThis isn't just one gene editāthis is multiple edits, working in concert. Itās a fundamentally different chassis.ā In this episode of The Biotech Startups Podcast, Aaron Edwards, co-founder of KiraGen Bio, shares how a Harvard Business School class project ignited the launch of a pioneering biotech taking on solid tumors with a bold, unconventional CAR T-cell therapy. He unpacks the real-world challenges of building KiraGenānavigating fundraising, assembling a strong team, and leveraging mentorship, partnerships, and machine learningāwhile highlighting how focus, discipline, and authentic leadership can set a startup apart, even when it means breaking from industry norms.
The Biotech Startups Podcast Ā· Excedr
Audio is streamed directly from the publisher (media.fame.so) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
- The Origin of KiraGen: Born from an HBS pitch deck, KiraGen set out to tackle immune suppression in solid tumors.
- Contrarian CAR T-Cell Design: Bold multi-edit strategy to outsmart tumor microenvironments and hit glioblastoma.
- Focus and Discipline: Lean operations, every dollar counts, eyes on clinical milestones.
- Creative Fundraising and Partnerships: Unconventional funding, academic alliances, and patient-driven capital.
- Authenticity and Team Building: Realness, inclusivity, and mentorship at the coreāpaying it forward in biotech.
Timestamps: